Proposal for Clinical Management of Nodules Diagnosed as Atypia of Undetermined Significance via Thyroid Fine‐Needle Aspiration Cytology in the Absence of Molecular Testing
Cytopathology · 2025
DOI: 10.1111/cyt.13467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytopathology, 2025. Verfasst von Ayana Suzuki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan. Hauptthemen laut MEDLINE: Thyroid Nodule, Thyroid Gland, Thyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Molecular testing is recommended for risk stratification of atypia of undetermined significance (AUS) nodules in the USA; however, it is not routinely performed in some countries owing to limited availability and affordability. Here, we propose a risk stratification algorithm for AUS nodules when molecular testing is unavailable.
Methods
We examined 304 (4.3%) AUS nodules among 7073 thyroid fine‐needle aspiration cytology specimens examined at Kuma Hospital from January 2020 to December 2020. Clinical data were obtained from the medical records of Kuma Hospital.
Results
AUS with nuclear atypia and AUS‐other each accounted for half of the total AUS nodules. The repeat aspiration rate was 19.7%; 61.7% of the nodules were reclassified as benign or malignant upon repeat aspiration. Resection rate and overall risk of malignancy (ROM) were 32.6% and 12.8%, respectively. Architectural atypia showed the lowest (1.1%) overall ROM in the AUS nodules. For AUS with nuclear atypia, nodules ≤ 10 mm in size showed significantly lower overall ROM than those of > 10 mm, and nodules with ultrasonographically low suspicion showed significantly lower overall ROM than those with intermediate to high suspicion. AUS nodules with atypical lymphoid cells, possible medullary thyroid carcinoma, or possible parathyroid lesion were confirmed using flow cytometry, biochemical testing using needle washout fluid or immunocytochemistry, respectively.
Conclusions
Our proposed clinical management algorithm for each subdivision according to cytological findings, based on repeat aspiration rates, ROM, ultrasound findings and results of ancillary tests except for molecular testing, should be useful for the clinical management of AUS nodules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan.
- Medical Information Management Section, Kuma Hospital, Kobe, Japan.
- Kudo Thyroid Clinic, Akashi, Japan.
- Department of Surgery, Kuma Hospital, Kobe, Japan.
- Department of Internal Medicine, Kuma Hospital, Kobe, Japan.
ORCID-Profile: Ayana Suzuki, Mitsuyoshi Hirokawa, Akira Miyauchi, Takashi Akamizu
Zitieren
APA
Suzuki, A., Hirokawa, M., Kawakami, M., Kudo, T., Miyauchi, A., & Akamizu, T. (2025). Proposal for Clinical Management of Nodules Diagnosed as Atypia of Undetermined Significance via Thyroid Fine‐Needle Aspiration Cytology in the Absence of Molecular Testing. Cytopathology. https://doi.org/10.1111/cyt.13467
Vancouver
Suzuki A, Hirokawa M, Kawakami M, Kudo T, Miyauchi A, Akamizu T. Proposal for Clinical Management of Nodules Diagnosed as Atypia of Undetermined Significance via Thyroid Fine‐Needle Aspiration Cytology in the Absence of Molecular Testing. Cytopathology. 2025. doi:10.1111/cyt.13467
BibTeX
@article{Suzuki2025,
author = {Suzuki, Ayana and Hirokawa, Mitsuyoshi and Kawakami, Makoto and Kudo, Takumi and Miyauchi, Akira and Akamizu, Takashi},
title = {Proposal for Clinical Management of Nodules Diagnosed as Atypia of Undetermined Significance via Thyroid Fine‐Needle Aspiration Cytology in the Absence of Molecular Testing},
journal = {Cytopathology},
year = {2025},
doi = {10.1111/cyt.13467}
}
EUVIMED